首页> 外国专利> ENHANCING ANTIGEN-SPECIFIC CD8+ T CELL RESPONSE USING IRF-7 MRNA

ENHANCING ANTIGEN-SPECIFIC CD8+ T CELL RESPONSE USING IRF-7 MRNA

机译:使用IRF-7 MRNA增强抗原特异性CD8 + T细胞反应

摘要

The invention provides compositions and methods useful for treating a subject in need thereof by stimulating an immune response. In some embodiments, the compositions and methods increase the population size of at least one type of CD8+ T cells in vivo or in vitro, such as transitory effector memory cells. The compositions are antigen-presenting cells that have been transfected with RNA encoding the regulatory factor IRF-7 as well as T cell populations induced by those APCs. In some embodiments, the APCs of the invention further comprise RNA encoding at least one antigen. The compositions of the invention can be administered to a subject to stimulate an immune response.
机译:本发明提供了通过刺激免疫应答可用于治疗需要其的对象的组合物和方法。在一些实施方案中,所述组合物和方法在体内或体外增加至少一种类型的CD8 + T细胞,例如瞬时效应记忆细胞的种群大小。该组合物是已经被编码调节因子IRF-7的RNA以及那些APC诱导的T细胞群体转染的抗原呈递细胞。在一些实施方案中,本发明的APC进一步包含编码至少一种抗原的RNA。可将本发明的组合物施用于受试者以刺激免疫反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号